News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Marketwire to Be Official Newswire of ExL Pharma's 5th PR & Communications Summit

5/27/2009 10:34:51 AM

NEW YORK, NY--(Marketwire - May 27, 2009) -

Marketwire and ExL Pharma are proud to announce their partnership for the 5th Annual Public Relations and Communications Summit, taking place at the Pfizer World Headquarters in Manhattan on July 27-28, 2009. Marketwire is now the official newswire of this leading meeting for communications professionals in pharmaceutical, biotechnology and medical device companies.

Featuring over forty-five speakers from top industry companies, this event will provide comprehensive presentations, panel discussions and opportunities for dialogue around issues that are most relevant to product, corporate and organizational communicators. Attendance is limited to 200 attendees due to space limitations, so anyone interested in joining us is encouraged to register now.

For full event details, please visit When registering, please use discount code: P228MW for a 5% discount of registration prices.

ExL Pharma's Lindsay Slater, conference director of the event, says, "We are receiving an overwhelming response to this event. With the outstanding caliber of speakers and companies represented, seats are going fast. Industry communicators are eager to hear from so many VPs from leading pharmaceutical companies and are especially looking forward to the FDA presentation. We are looking forward to an extremely productive and interactive meeting."

This event will provide concrete strategies for a range of topics relevant to PR professionals, including how to prepare for and anticipate change within internal and external communications, as well as how to manage fears and concerns in an uncertain economy.

"We are thrilled to be partnering with an organization of this caliber," said Marketwire Vice President Sylvie Harton. "And we look forward to providing EXL Pharma's attendees and sponsors with the latest tools, services and technologies to enhance the reach of their news and information."

Now in its fifth year, the PR and Communications Summit has earned tremendous accolades from past attendees:

"This conference was excellent. Top notch speakers and terrific networking opportunities with industry colleagues." -- PR Director, SANOFI PASTEUR

"Great overview of what is current and relevant to US Pharma and biotech and excellent speaking faculty." -- Vice President, Global Communications, SERONO

Highlighted sessions include:


The Pharmaceutical Industry Saves Millions of Lives, but Can it Save Itself?

-- Steve Lampert, Executive Director, Corporate Affairs, ASTRAZENECA -- Richard Salem, Executive Director, Public Affairs, DAIICHI SANKYO -- Tim Hunt, Vice President, Public Affairs, BIOGEN IDEC -- David Krawitz, Executive Director, Global Reputation Management & Product Communications, AMGEN

Building an Effective Relationship between the Pharmaceutical Industry and FDA in the Changing Environment

-- Julie Zawisza, Director, Office of Communications, FDA CENTER FOR DRUG EVALUATION AND RESEARCH


Partnering with Advocacy Groups and Associations to Communicate the Value Of Your Products

-- Rachel Bloom-Baglin, Executive Director, Corporate Communications, ASTRAZENECA -- Stacey Beckhardt, Associate Director, Product Communications, CEPHALON -- Erica Wishner, Director, Consumer Marketing, ACORDA THERAPEUTICS


The Increasing Dependence on Wire Services and the Evaporation of In-Depth, Investigative Health Care Journalism

-- Panel Moderator: Christopher Loder, Head, US Media Relations, PFIZER -- Panelists: Senior Journalists from BLOOMBERG, REUTERS, BNET and Others

About ExL Events

ExL Pharma, a division of ExL Events, Inc., is an emerging international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community. For more information visit

About Marketwire

The only fully integrated North America-based global newswire, Marketwire, Inc. is a full-service partner to IR, PR and MarCom professionals seeking top-tier press release distribution, media management, multimedia and monitoring solutions. Marketwire's customer-centric corporate philosophy focuses on being the best by infusing every aspect of its business with the following core attributes: precision, adaptability, innovation and simplicity.

Marketwire delivers its clients' news to the world's media and financial communities, fulfilling disclosure requirements in North America in compliance with the Securities and Exchange Commission (SEC) and the Toronto Stock Exchange (TSX), and serving as Primary Information Provider (PIP) with the UK's Financial Services Authority (FSA). With a reputation for technology leadership, Marketwire offers innovative products and services -- including Social Media, Search Engine Optimization, Dashboard Mobile Financial, News Dashboard coverage reports, exclusive access to networks such as the Canadian Press Wire Network, Easy IR and Easy PR workflow solutions, and more -- that help communication professionals maximize their effectiveness while ensuring accuracy and best practices. Having merged companies (Market Wire and CCNMatthews) in April 2006, and enjoying a combined history of 25 years of service, Marketwire is now majority-owned by OMERS Capital Partners, the private equity arm of one of Canada's largest pension funds.

Marketwire distributes the majority of press releases issued by publicly traded companies in Canada and serves more than 8,000 clients worldwide through 20 offices on four continents. For more information, visit us at


ExL Pharma
Lindsay Slater
Phone 212-400-6233
Email Contact

Saul Slotnick
Phone 212-542-3013
Email Contact

Digg this    Bookmark with    Add to Newsvine


Read at

comments powered by Disqus